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Abstract 
The nucleoprotein (NP) of the influenza A virus encapsidates the viral RNA and participates 
in the infectious life cycle of the virus.  The aims of this study were to find the degree of 
conservation of NP among all virus subtypes and hosts and to identify conserved binding 
sites, which may be utilised as potential drug target sites. The analysis of conservation based 
on 4430 amino acid sequences identified high conservation in known functional regions as 
well as novel highly conserved sites. Highly variable clusters identified on the surface of NP 
may be associated with adaptation to different hosts and avoidance of the host immune 
defence. Ligand binding potential overlapping with high conservation was found in the tail-
loop binding site and near the putative RNA binding region. The results provide the basis for 
developing antivirals that may be universally effective and have a reduced potential to 
induce resistance through mutations. 
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Introduction 
The influenza A virus causes a respiratory disease resulting in annually recurring epidemics 
affecting an estimated 3-5 million people and about 250,000 to 500,000 deaths worldwide 
(WHO, 2009). At the same time the influenza virus causes substantial losses among 
domesticated birds (Leibler et al., 2009). Apart from epidemics, influenza A viruses have 
been responsible for devastating pandemics killing at least 40 million people in 1918/1919 
(Spanish Flu, H1N1) (Johnson and Mueller, 2002) and less serious pandemics in 1957 (Asian 
Influenza, H2N2), 1968 (Hong Kong Influenza, H3N2), 1977 (Russian Influenza, H1N1) (Cox 
and Subbarao, 2000) and the latest pandemic (Swine Flu, H1N1) killing an estimated 284,000 
people (Dawood et al., 2012).  Influenza pandemics seem to occur when a pathogenic 
animal-type virus acquires the capability of efficient human to human transmission 
(Horimoto and Kawaoka, 2005), which may occur due to mutations or reassortment of 
human and animal RNA segments (Lin et al., 2000). A current threat, besides the avian H5N1 
virus, is an avian H7N9 virus emerging in China that has caused 104 confirmed infections 
including 21 deaths (WHO, 2013).  Due to the high mutation rate and emerging resistance 
against neuraminidase inhibitors (Ferraris and Lina, 2008) and amantadine/rimantadine 
(Rahman et al., 2008), it is of utmost importance to investigate other viral proteins as 
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potential drug targets for example the non-structural proteins (Darapaneni, Prabhaker, and 
Kukol, 2009).   
The influenza A virus belongs to the family Orthomyxoviridae.  It is a lipid-enveloped virus 
with a negative-strand RNA genome organized into eight separate segments, which code for 
eleven or more proteins dependent on the particular virus strain (reviewed in e.g. in Das et 
al. (2010)). Based on the antigenic properties of the proteins haemagglutinin and 
neuraminidase the virus is classified in subtypes HxNy. Segment five encodes the 
nucleoprotein (NP). The primary function of NP is to encapsidate the segmented RNA and 
bind with the three polymerase subunits, PA, PB1 and PB2, to form ribonucleoprotein 
particles (RNPs) for RNA transcription, replication and packaging (Du, Cross, and Zhou, 2012). 
The molecular structure of NP from an H1N1 virus (Ye, Krug, and Tao, 2006) and an H5N1 
virus (Ng et al., 2008) has been elucidated by x-ray crystallography. NP is composed of a 
head domain, a body domain, and a flexible tail loop (figure 1A). In each RNP, the viral RNA 
wraps around individual NP molecules, in an arginine-rich RNA-binding groove (Marklund et 
al., 2012; Ng et al., 2008) (figure 1A).  NP oligomers are formed by insertion of the tail loop 
of one NP molecule into the tail loop binding pocket of another, via a crucial salt bridge 
between Glu339 and Arg416 (Coloma et al., 2009; Shen et al., 2011).  
Influenza NP is the most abundantly expressed protein during the course of infection, with 
multiple functionalities including viral RNA synthesis and RNP trafficking, polymerase 
regulation and interaction with cellular polypeptides, including actin (Li et al., 2009; Portela 
and Digard, 2002). Various nuclear localisation signals (NLS) in the amino acid sequence of 
NP are critical for nuclear import of the whole polymerase complex (reviewed in (Hutchinson 
and Fodor, 2012)). The N-terminus contains an unconventional NLS, which becomes 
deactivated after Ser-3 phosphorylation (Wu and Pante, 2009). A potential bipartite NLS was 
identified in the RNA binding groove betwee residues 198 and 216 (Weber et al., 1998) and a 
third NLS between residues 320 and 400 was identified based on deletion studies (Wang, 
Palese, and ONeill, 1997). Overall it appears that the N-terminal unconventional NLS is the 
major determinant of nuclear import (Cros, Garcia-Sastre, and Palese, 2005), while a nuclear 
accumulation signal between residues 327 and 345 potentially acts to retain NP in the 
nucleus (Davey, Dimmock, and Colman, 1985). NP has been identified as a target for drug 
discovery, and some potential inhibitors acting against the NP protein were identified, 
namely nucleozin that triggered aggregation of NP (Kao et al., 2010), NP oligomerisation 
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inhibitors (Shen et al., 2011) and the RNA-binding inhibitor naproxen (Lejal et al., 2013). 
Analyses of NP sequences at the amino acid or nucleotide level have been conducted 
previously. A large scale study by Xu et al. (2011) of based on 5094 NP nucleotide sequences 
split into different evolutionary linages identified six highly variable sites and a few hundred 
conserved sites, the number of which depend on the evolutionary linage and methodology 
used to calculate conservation. A review article reported the fraction of conserved amino 
acid residues in secondary structure elements (Ng, Wang, and Shaw, 2009), but no clear 
definition of conservation was given. Most references to sequence conservation of NP in the 
literature (e.g. Mena et al., 1999; Ng, Wang, and Shaw, 2009) go back to a study conducted 
by Shu et al. (Shu, Bean, and Webster, 1993) based on multiple alignment of 49 sequences.  
The aims of the current study were to identify the degree of conservation of NP among all 
influenza A virus subtypes from all hosts in order to identify sites of universal conservation. 
The mapping of the conservation scores onto the three-dimensional structure together with 
an analysis of the small-molecule binding potential suggests potential binding sites for 
antivirals that may be universally applicable without leading to resistance. Furthermore, our 
results suggest highly conserved sites with unknown function which could be further 
investigated experimentally. 
 
Methods 
Sequence analysis 
The protein sequences of the influenza A virus NP were obtained from the National Center 
for Biotechnology information (NCBI) influenza virus resource (Bao et al., 2008). Sequences 
from all virus subtypes and all hosts were chosen. Sequence redundancy was removed by 
identifying clusters of sequences at 99% identity and replacing a cluster with a 
representative sequence using the CD-HIT suite (Huang et al., 2010). After the removal of 
sequences containing undefined amino acid residues the remaining sequences were 
subjected to multiple alignment with MUSCLE software (Edgar, 2004a; Edgar, 2004b) using 
an iterative refinement until convergence of the sum-of-pairs score was achieved, which 
yields the most accurate alignment. After conversion of the alignment to the Phylip format 
(Futami et al., 2008), a phylogenetic tree was calculated with PhyML 3.0 based on the 
maximum-likelihood method (Guindon et al., 2010) using the influenza-specific amino acid 
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substitution model FLU (Cuong et al., 2010). Multiple sequence alignments were visualised 
with Jalview (Waterhouse et al., 2009). 
 
Protein Structure 
The crystal structure of NP from the influenza A virus subtype H5N1 (Ng et al., 2008) was 
obtained from the RCSB Protein Data Bank (Berman et al., 2000) with the identifier 2QO6. 
This structure was chosen, because the number of missing residues (from 79-86) was less 
than in than in a similar NP structure from an H1N1 virus with the identifier 2IQH (Ye, Krug, 
and Tao, 2006). The coordinate file was manually split into a monomer, and a continuous 
model from Ala22 to Tyr496 was obtained from the i-TASSER server 2.0 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) (Zhang, 2008) explicitly specifying the 
structure of 2QO6 as a template. None of the templates identified covered the missing 
region 79-86, thus according to the i-Tasser protocol, ab-initio modelling was applied with a 
knowledge-based force field (Wu, Skolnick, and Zhang, 2007). The final protein structure 
used for further analysis was obtained by copying the structural information of residues 
Tyr78 to Lys87 obtained from I-TASSER into the monomer crystal structure. 
 
Conservation analysis 
The conservation of amino acid residues was obtained and projected onto the protein 
structure using the ConSurf 2010 server (Ashkenazy et al., 2010; Celniker et al., 2013; Landau 
et al., 2005). The ConSurf algorithm takes into account the evolutionary relationships 
between protein sequences giving a greater weight to evolutionary more distant sequences. 
This is essential for producing meaningful conservation scores, since the protein sequences 
show high similarity due to originating from the same species. The protein structure pdb-file, 
the multiple sequence alignment and the phylogenetic tree calculated with the FLU 
substitution model (Cuong et al., 2010) were uploaded manually and the Bayesian statistic 
method was chosen. The resulting conservation scores are standard scores with an average 
of zero and a standard deviation of one. A score below zero denotes higher than average 
conservation. Confidence intervals of conservation scores were calculated with Bayesian 
statistics (Mayrose et al., 2004). For assigning conservation grades (1-9), the scores below 
and above zero are divided into 4½ intervals each, which form the nine conservation grades. 
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The interval for the lowest conservation grade 1 is expanded to include residues with the 
highest variability (Ashkenazy et al., 2010).  A table of detailed results including statistical 
confidence intervals is available as supporting information. 
 
Binding site prediction 
Potential binding sites were predicted by two different methods, namely computational 
solvent mapping with FTMap that involves docking a library of small organic solvent-like 
molecules to the protein structure (Brenke et al., 2009) and QsiteFinder that scans the 
protein surface with a methyl van Waals probe for favourable interactions (Fuller, Burgoyne, 
and Jackson, 2009). Clusters of docked solvent molecules in case of FTMap or clusters of 
methyl probes in case of QSiteFinder can identify potential hot spots of binding. The FTMap 
binding sites are ranked based on the number of overlapping clusters of solvent molecules, 
while the QsiteFinder binding sites are ranked according to the total interaction energy. Both 
rankings implicitly take into account the volume of the binding site. The predicted binding 
sites and conservation scores were combined by manually transferring the coordinates of 
binding sites to the coordinate file (pdb-file) obtained from the ConSurf server. Protein 
structures with conservation scores and predicted ligand binding sites are available as 
supporting information. Figures of protein structures were prepared with Rasmol (Sayle and 
Milnerwhite, 1995). 
 
Results 
Influenza virus sequences 
Initially 4430 sequences of influenza A virus NP of all subtypes and hosts were obtained. 
After clustering of sequences at 99% identity threshold, 815 sequences remained that 
showed at least 1% sequence difference. Among the sequences there were 33% from 
human, 26% from swine, 15% from chicken and 12% from duck hosts; the remaining 14% 
were from a variety of species including turkey, quail, mallard, horse, dogs as well as a 
variety of birds. 
Conserved amino acid residues 
The evolutionary conservation of amino acid residues in the NP protein were identified using 
the ConSurf server (Ashkenazy et al., 2010; Landau et al., 2005). Conservation scores were 
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obtained between -0.78 (highest conservation) and 4.8 (highest variability) and assigned to 
grades between 9 (highest conservation) and 1 (highest variablity) by the ConSurf server. 
Highly conserved residues (grades 8–9) and variable residues (grades 1–3) are shown in table 
1.  Conservation grades were mapped to the protein backbone (figure 1A, B). Overall the 
protein is highly conserved with 59% of residues in the highest conservation grades 7-9, 
while 21% of residues are highly variable with grades 1-3. A significant number of 38 
residues highlighted in table 1 show no variation at all among the 4430 sequences analysed.  
Figure 1C and figure 2 show the conservation mapped onto the protein structure. The first 
N-terminal helix shows a pattern of conservation that is mainly confined to one face of the 
helix starting with Ile25 (grade 8) followed by Ser28 (grade 9), Met32, Ile36, Tyr40, Gln42-
Glu46. Another helix inside the body domain that packs against the single antiparallel beta-
sheet present in NP has high conservation at residues Gln58, Ser60 (grade 8), Thr62, Met 66 
and Ser69 (all grade 9). The following loop until Glu81 contains several highly conserved 
residues, such as Glu73, Arg74, Arg75, Asn76, and Glu80. Note that a part of this sequence 
from Leu79-Gly86 was not resolved in the original structure, but is based on computational 
modelling. This high conservation is mirrored by an opposite loop from Gly169 (grade 9) to 
Ser176 (grade 8). Both loops overlook a highly conserved α-helix from Gly132 to Thr147. The 
end of this α-helix marks the transition into the head domain. Two short α-helices Thr151-
Thr157 and Asp160-Ser165 with highly conserved features precede the second loop just 
described. This loop is followed by a four-helix bundle from Gly185-Leu264 after which the 
chain transits into the body domain. The four helix-bundle contains some variable as well as 
highly conserved residues, notably Gly185, Arg208, Gly212, Arg221, Cys223, Glu252, Glu254, 
Arg261, Ser262 and Ala263 are all conserved at grade nine. Inside the body domain from 
Lys273 until Arg391 some occurrences of highly variable residues are observed. The amino 
acid chain then forms the tail loop from approximately Arg400 to Lys430. Notably, some 
residues in the tail loop show high conservation at grades eight or nine, such as Ser407, 
Gln409, Pro410, Phe412, Ser413, Val414, Gln415 and Pro419. The tail-loop binding pocket is 
formed by residues not adjacent in sequence and its conservation is shown in table 3 and 
discussed further in the next section. The tail loop is then followed by another α-helix with 
highly conserved Ile445, Glu449 and Ser450. The chain traverses again to the body domain, 
where it reveals a well-resolved structure composed of largely non-repetitive secondary 
structure elements. Very high conservation is found in this region at Ser457, Gly460, Val463, 
Glu465, Ala471, Val476, Pro477 and Ala493.  
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On the other hand we found clusters of highly variable regions. Ser50, Gln52 and Phe313 
form a small highly variable (grade 1) cluster on the surface of the body domain. A 
continuous patch of variable sites is formed by Arg98, Arg100, Asp101, Gly102, Lys103, 
Val105, Glu372, Ala373, Met374, Asp375 and Pro318. Another area of variable sites is 
formed by Thr350, Arg351, Ile353 and Tyr496 (figure 2). 
A consensus sequence calculated from the multiple alignment was compared to the human 
influenza A pandemic NP sequences in figure 3. At residue 100 there is a striking difference 
between the consensus sequence and pandemic sequences, namely the consensus residue 
Arg100, is replaced by hydrophobic residues Ile and Val in human pandemic sequences. At all 
other variable positions the same or a similar residue to the consensus is found in at least 
one of the pandemic sequences. 
 
Small-molecule ligand binding potential 
The binding potential of NP for small molecule drugs was predicted based on clusters of 
energetically favourable interaction sites with a methyl-probe (Q-SiteFinder (Laurie and 
Jackson, 2005)) and docking of a library of small organic solvent molecules (FtMap (Brenke et 
al., 2009)). The spatial arrangement of binding sites is shown in Figure 4 for both methods. 
The binding sites are mainly located in the body domain with some sites at the interface 
between head and body domain. FTMap identified a number of sites within the binding 
pocket of the tail loop, namely F1, F2, F4, F4, F5, F9 (‘F’ denotes binding sites identified by 
FTMap, while the number indicates the rank assigned by the algorithm). Further binding 
sites F3 and F8 were found in the RNA binding region, while F7 is located in a different 
region of the protein. Q-SiteFinder identified binding sites in similar as well as different 
locations. Similar binding sites are Q3 and Q7, which are located in the tail loop binding 
pocket. The highest-ranked binding Q1 is located in the RNA binding region. Q4 and F7 are in 
similar regions, while there is not much agreement between the other binding sites. 
An important aim of the present work was to identify binding sites that are spatially close to 
conserved amino acid residues. Table 2 identifies residues, which are in close proximity of 
the binding sites. The highest ranked sites have a large volume, thus spatially distant 
residues are included. The number of residues included in table 2 does not relate to the 
ranking of binding sites, but to the number of residues which are in close proximity based on 
the arbitrary cut-off of 0.3 nm. As shown in table 2, most predicted binding sites are close to 
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one or more highly conserved residues, except F4, Q3, Q8 and Q9. Notably the three highest 
ranked sites F1, F2 and F3 are in close proximity to conserved residues, while two highest 
ranked sites of the ConSurf method Q1 and Q2 are close to conserved residues. 
 
 
Discussion 
Sequence conservation 
The objective of this study was to determine the degree of conservation of NP among all 
sequenced influenza A viruses isolates and to identify small-molecule binding sites in 
conserved regions, which may form potential target sites for future antiviral drug discovery.  
The protein structure of NP was based on the recently published X-ray structure (Ng et al., 
2008) of an H5N1 isolate with the missing amino acids residues 79-86 build by ab-initio 
modelling with the i-Tasser server (Zhang, 2008). Sequence conservation may arise due to 
functionally important sites, such as interaction sites or targeting signals, sites important in 
maintaining the protein structure (Schueler-Furman and Baker, 2003) or on the RNA level as 
packaging signals (Gog et al., 2007). Variable sites on the other hand may arise due to 
adaptation to different hosts or due to evolutionary pressure to escape the host immune 
system. Significant amounts of NP were detected on the surface of infected cells, which 
enables the detection by the host immune system (Yewdell, Frank, and Gerhard, 1981). 
In established functionally important regions we find high conservation, for example in the 
bipartite nuclear localisation signal (residues 198 to 216) (Wang, Palese, and ONeill, 1997), 
Trp207, Arg208, Gly209 and Gly212 are conserved at grade 9. In addition it was shown that 
Arg204, Trp207 and Arg208 bind to the viral polymerase (Marklund et al., 2012). In the 
nuclear accumulation signal (residues 327 to 345) (Davey, Dimmock, and Colman, 1985) 
Ala332, Ala337 and Glu339 are conserved at grade 9. Significant conservation was found 
near the putative RNA binding grove in two flaps overlooking a highly conserved α-helix 
(figure 1). Previously it was found that mutation of Asp72, Arg74, Lys113, Arg156, Arg174, 
Arg175, Arg195, Arg199, Lys325 and Arg361 to alanine impaired the incorporation of viral 
RNA (Li et al., 2009). All of those residues except Arg174 and Arg195 are conserved at grade 
8 or 9. Another region of conservation can be found in the tail loop (residues 402-428), 
which facilitates NP oligomerisation by binding to a corresponding pocket formed between 
the NP body and head domain. Gln409, Pro410, Phe412, Gln415 and Pro419 in the tail loop 
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are conserved at grade 9, while many other residues including Arg416 show conservation at 
grade 8. The mutation Phe412Ala was shown to decrease the transcription of viral RNA (Li et 
al., 2009). Figure 5 shows the binding of the tail loop into a cavity between head and body 
domain. 
Table 3 shows the conservation grades of residues of the tail loop binding pocket, which are 
in close contact with the tail loop. Notable the mutation Arg267Ala decreased the assembly 
of the viral NP by 50%, while the Glu339Ala completely abolished NP formation (Chan et al., 
2010). Also mutation of the highly conserved Glu449 located near to the tail loop in the helix 
of the head domain decreases assembly of NP (Chan et al., 2010). It was recently shown that 
isolated NP exists in equilibrium between monomers and trimers and mutations Arg416Ala, 
Glu339Ala stabilise the monomeric form, while Tyr148Ala shifts the equilibrium to the 
trimeric form (Chenavas et al., 2013). Arg416 is located in the tail loop and shows a limited 
residue variety of Arg, Lys and Gly with a conservation grade of 8. While the wild-type 
monomer cannot be crystallised, a crystal structure of the monomeric mutant Arg416Ala 
showed that the tail loop is folded onto its own body domain covering the tail loop binding 
site (Chenavas et al., 2013). Furthermore, Chenavas et al (Chenavas et al., 2013) postulated 
that the wild-type monomer is stabilised by phosphorylation of Ser165 and showed using 
biophysical measurements that a phosphomimetic mutation Ser165Asp leads to a 
monomeric NP. This explains the high conservation of Ser165 (table 3) that only allows for a 
substitution by a Thr residue in some virus isolates. 
Additionally we identified areas on the surface of NP that showed significant variation (figure 
2). Some of the variation can be explained by adaptation to different hosts. It was shown 
that mutations of the residue 313 confers resistance to the human interferon-induced Mx1 
protein (Manz et al., 2013). Mx1 has a known antiviral activity against RNA viruses by binding 
to their ribonucleocapsid (Haller, Staeheli, and Kochs, 2007). In addition residues 53, 100, 
283 and 289 were shown to cause Mx1 resistance (Manz et al., 2013). Of those only residues 
100 and 283 are highly variable, while Gly53 is conserved at grade 7 and Tyr289 is conserved 
at grade 6, albeit there was insufficient data to reliably assign the conservation of Tyr289. 
Notably, pandemic influenza strains have hydrophobic Ile or Val at position 100, while the 
consensus is the positively charged Arg residue (figure 3).  The significance of other highly 
variable clusters remains to be established. Notably, NP was detected on the surface of 
infected cells, which enables the detection by the host immune system (Yewdell, Frank, and 
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Gerhard, 1981). Evolutionary pressure to avoid the host immune system may explain some 
of this variation. 
Small-molecule ligand binding potential 
A significant binding potential for small molecule ligands was found in the tail loop binding 
pocket. Some of the highest ranked sites, such as F1 and F2, were found here in proximity of 
highly conserved residues (table 2). This pocket has already been exploited for the 
development of influenza virus inhibitors with the strongest inhibitory activity (IC) of 
IC50 = 2.7 µM shown by an organic molecule (Shen et al., 2011). Based on our results one can 
predict, that compounds targeting this pocket are unlikely to be become ineffective due to 
virus resistance, since residues in this pocket are highly conserved among virus subtypes and 
different host organisms. A study by Kao et al. (2010) identified nucleozin and analogues as a 
replication inhibitor with an IC50 between 0.07 and 0.33 μM for different virus isolates. A 
mutation Tyr289His was identified as the only mutation contributing to resistance of an 
escape mutant after five passages of selection indicating that the binding site for nucleozin is 
located close to Tyr289. This corresponds to the binding site Q9 identified in the present 
study (table 9), which is not located close to highly conserved region explaining the 
emergence of escape mutants in the previous study. 
Another potential binding site for small molecule ligands in the RNA binding region was 
detected as sites F3, F8 and Q1, Q6. These binding sites are close to a highly conserved helix, 
thus resistance against inhibitors is unlikely to develop. The residue Tyr78 close to Q1 is 
located on a flexible loop, which can enable the access of small molecule ligands to Q1. It 
was shown that flexibility of the two loops overlooking Q1 is required for NP activity (Tarus 
et al., 2012). Thus any ligand binding to Q1 that interacts with loop residues such as Tyr78 
could reduce loop flexibility and inhibit RNA binding. That binding site has not yet been 
explored for development of influenza virus inhibitors. However, recently the anti-
inflammatory drug naproxen has been shown to inhibit RNA binding to NP and reduced viral 
titres with EC50 = 11 μM (Lejal et al., 2013). Based on molecular docking and site-specific 
mutagenesis a binding site in proximity to Q2 was detected. The mutations Tyr148Ala and 
Arg361Ala abolished the ability of naproxen to inhibit RNA binding. Furthermore, no escape 
mutants were detected after six passages of selection, as it would be expected based on our 
conservation analysis of the Q2 binding site shown in table 2. 
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    Other binding sites are also in contact with conserved amino acid residues, such as Q10 
and F9.  While these binding sites received low ranks from the detection algorithm, the 
nucleozin example mentioned above (Kao et al., 2010) shows that even low ranking binding 
site have a potential to bind small organic molecules, possibly due to a conformational 
change of the protein, which the binding site detection algorithms do not take into account. 
Some lower ranking binding sites may be involved in NP-NP interactions, since NP exists as 
oligomers in the ribonucleprotein complex. 
Conclusion 
A study of 4430 nucleoprotein sequences reveals a high sequence conservation that overlaps 
with potential binding sites rendering the nucleoprotein an excellent drug-target for small-
molecule antiviral drug discovery. Targeting the tail loop binding pocket or potential binding 
sites near the RNA binding region are the most promising strategies for antivirals that are 
unlikely to lead to resistance in the future, since the binding sites are conserved among 
different subtypes and hosts. Furthermore, antivirals targeting these sites are likely to be 
universally effective against viruses of avian, swine or human origin. 
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Tables 
 
Table 1:  Conserved residues (conservation grades 8–9) and variable residues (conservation 
grades 1-3) of the NP protein identified using the ConSurf server (Ashkenazy et al., 2010). 
Residues in bold print do not show any variation. 
 
Residue 
Classification 
NP protein 
Conserved 
(grades 8-9) 
Ile25, Ser28, Val29, Met32, Ile36, Gly37, Tyr40, Gln42, Met43, Cys44, Thr45, Glu46, Asp51, 
Arg55, Gln58, Asn59, Ser60, Thr62, Met66, Ser69, Ala70, Phe71, Asp72, Glu73, Arg74, 
Arg75, Asn76, Tyr78, Glu80, Pro83, Lys87, Asp88, Pro89, Lys90, Thr92, Gly93, Gly94, Tyr97, 
Arg106, Leu110, Lys113, Trp120, Ala123, Asn124, Gly132, Thr134, His135, Met137, Ile138, 
His140, Ser141, Asn142, Leu143, Asn144, Asp145, Thr147, Arg150, Thr151, Ala153, Leu154, 
Val155, Arg156, Gly158, Asp160, Pro161, Met163, Cys164, Ser165, Leu166, Met167, 
Gly169, Ser170, Thr171, Leu172, Pro173, Arg175, Ser176, Ala178, Ala179, Ala181, Gly185, 
Gly187, Thr188, Met196, Arg199, Asn205, Phe206, Trp207, Arg208, Gly209, Gly212, 
Arg213, Ala218, Glu220, Arg221, Cys223, Leu226, Lys227, Gly228, Lys229, Thr232, Ala233, 
Gln235, Met238, Asp240, Gln241, Arg243, Pro248, Asn250, Ala251, Glu252, Glu254, 
Arg261, Ser262, Ala263, Arg267, Ala271, Lys273, Ser274, Val285, Gly288, Phe291, Ser297, 
Val299, Gly300, Asp302, Pro303, Gln308, Gln311, Ser314, Arg317, Glu320, His324, Lys325, 
Gln327, Leu328, Ala332, Ala336, Ala337, Glu339, Asp340, Arg342, Phe346, Arg348, Gly349, 
Pro354, Arg355, Arg361, Ala366, Thr378, Ser383, Tyr385, Ala387, Ile388, Ser392, Gln405, 
Ser407, Gln409, Pro410, Phe412, Ser413, Val414, Gln415, Arg416, Pro419, Thr424, Ala427, 
Phe429, Glu434, Arg436, Asp439, Ile445, Met448, Glu449, Ser457, Phe458, Gly460, Gly462, 
Val463, Glu465, Ser467, Ala471, Val476, Pro477, Phe489, Asp491, Ala493 
Variable (grades 
1-3) 
Ala22, Arg31, Val33, Gly34, Arg38, Ile41, Ser50, Gln52, Gly54, Ile61, Ile63, Arg77, Ser84, 
Ala85, Arg98, Arg100, Asp101, Gly102, Lys103, Val105, Ile109, Tyr111, Glu114, Arg117, 
Ile119, Asn125, Glu127, Asp128, Met136, Ala146, Ile183, Val186, Met189, Val190, Ile194, 
Ile197, Ile201, Arg214, Ile217, Phe230, Lys236, Met239, Ile253, Ile257, Leu259, Leu283, 
Asp290, Arg293, Ile301, Leu306, Phe313, Pro318, Ala323, Val329, Leu341, Val343, Ser344, 
Thr350, Arg351, Val352, Ile353, Gln357, Leu358, Val363, Val371, Glu372, Ala373, Met374, 
Asp375, Ser377, Arg384, Arg391, Asn397, Gln398, Arg400, Ile406, Val408, Asn417, Leu418, 
Arg422, Ala423, Ile425, Lys430, Asn432, Thr433, Arg446, Ser450, Arg452, Pro453, Val456, 
Leu466, Thr472, Asn473, Asp480, Met481, Ser482, Asn483, Gly485, Asn492, Glu494, 
Glu495, Tyr496 
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Table 2: Amino acid residues within 0.3 nm of predicted binding sites. Conserved residues 
with grade 8 or 9 are shown in bold face. 
 
FTMap ConSurf 
Site Amino acid residues Site Amino acid residues 
F1 Ser344, Ala387, Ile388 Q1 Tyr78, Ser141, Thr171 
F2 Ser165, Val186, Ala263, Gly268, Ile270, Ser392 Q2 Asp145, Tyr148, Arg150 
F3 Gln58, Thr62, Tyr97, Ile365 Q3 Phe304, Trp330, His334, Ile347 
F4 His272, His334, Ser335, Thr390 Q4 Asp51, Gly54 
F5 Ile388, Arg461, Gly462 Q5 Arg342, Phe479, Asn483, Glu484 
F6 Ala337, Phe338, Glu339, Ser486, Phe489 Q6 Gln58, Thr62, Tyr97 
F7 Tyr40, Gly54 Q7 Ser165, Phe488, Phe489 
F8 Ala131, Thr134, His135, Lys273 Q8 Leu307, Ser310, Val312, Leu279, Leu381 
F9 Glu339, Asp340 Q9 Tyr289, Arg305, Asn309 
  Q10 Arg74, Arg174, Arg175 
 
 
 
Table 3: Amino acid residues in the tail loop binding pocket close (0.3 nm) to the tail loop 
 Residue Conservation 
grade 
Gln149 
Ser165 
Leu264 
Arg267 
Ile270 
His272 
Ser335 
Phe338 
Glu339 
Arg342 
Thr390 
Gln459 
Phe489 
7 
9 
7 
9 
5 
9 
6 
6 
9 
8 
7 
4 
8 
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Figure 1:  A) Structure of NP showing tail loop (yellow), head (blue) and body domain 
(green). Residues contributing to RNA binding are shown in ball-and-stick representation. B), 
C) Structure and amino acid sequence of NP, colour coded by conservation scores as 
indicated in the colour legend. 
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Figure 2: Spacefill representation of the NP structure (PDB-id 2Q06) with conservation 
grades mapped on the structure. See figure 1 for colour legend. Significant residues 
discussed in the text are labelled. 
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Figure 3: Multiple sequence alignment of a consensus sequence calculated from all 
sequences used in this study with sequences from influenza A pandemics and the sequence 
of the protein structure 2Q06. The sequence alignment is coloured by conservation based on 
the BLOSUM62 matrix (Henikoff and Henikoff, 1992). The 2Q06 sequence is coloured 
according to conservation as in figure 1. 
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Figure 4: Ligand binding sites identified by FtMap (A) and Q-SiteFinder (B). The numbers 
indicate the ranking assigned by the algorithms, which ‘1’ denoting the highest ranked 
binding site. 
 
 
Figure 5: Illustration of the interaction between the tail loop and its binding pocket. The tail 
loop is based on the structure PDB-ID 2IQH (Ye, Krug, and Tao, 2006) that was fitted onto the 
2QO6 structure analysed here. 
